Effects of Lemborexant on Insomnia and Its Relationship to Mood and Behavior on Opioid Use Disorder Subjects
Phase 2
100
about 4.2 years
18+
1 site in VA
About this study
This trial is testing a treatment called lemborexant for insomnia in people with opioid use disorder. The goal is to see how this medication affects sleep, mood, and behavior. Researchers will compare lemborexant to a placebo (sugar pill) over 8 weeks to measure improvements on these factors.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Lemborexant 10 MG
- 2.Take Placebo
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
lemborexant
oral (Oral Tablet)
Secondary: Negative Emotionality: General Anxiety Disorder (GAD-7), Negative Emotionality: Patient Health Questionnaire (PHQ-9)
Psychiatry / Mental Health